INTRINSIC MEDICINE

Serial Number 97587531
603

Registration Progress

Application Filed
Sep 12, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

INTRINSIC MEDICINE

Basic Information

Serial Number
97587531
Filing Date
September 12, 2022
Abandonment Date
June 25, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
603
Status Date
Jun 25, 2025
Classes
005

Rights Holder

Intrinsic Medicine, Inc.

03
Address
500 Yale Avenue North
Seattle, WA 98109

Ownership History

Intrinsic Medicine, Inc.

Original Applicant
03
Seattle, WA

Legal Representation

Attorney
EMILIA F CANNELLA

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

30 events
Date Code Type Description Documents
Jun 25, 2025 MAB3 E ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL Loading...
Jun 25, 2025 EXPT T EXPARTE APPEAL TERMINATED Loading...
Jun 25, 2025 EXDD T EXPARTE APPEAL DISMISSED Loading...
Jun 25, 2025 ABN3 O ABANDONMENT - AFTER EX PARTE APPEAL Loading...
Apr 23, 2025 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Apr 23, 2025 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Jan 23, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jan 23, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Oct 23, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 23, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 23, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Jul 18, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 18, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 18, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 18, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Apr 18, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jan 18, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 18, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 18, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 21, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 21, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 21, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 22, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Sep 22, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 25, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 25, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 25, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 24, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 27, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention, inhibition and treatment of gastrointestinal diseases and disorders, autoimmune diseases and disorders, inflammatory diseases and disorders, developmental diseases and disorders, degenerative diseases and disorders, metabolic diseases and disorders, cancer, pain, frailty, inflammation, and infection

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICINE"